223 related articles for article (PubMed ID: 30669865)
1. Etoposide encased folic acid adorned mesoporous silica nanoparticles as potent nanovehicles for enhanced prostate cancer therapy: synthesis, characterization, cellular uptake and biodistribution.
Saroj S; Rajput SJ
Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S1115-S1130. PubMed ID: 30669865
[TBL] [Abstract][Full Text] [Related]
2. Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles.
Fan J; Fang G; Wang X; Zeng F; Xiang Y; Wu S
Nanotechnology; 2011 Nov; 22(45):455102. PubMed ID: 22019849
[TBL] [Abstract][Full Text] [Related]
3. Facile development, characterization, and evaluation of novel bicalutamide loaded pH-sensitive mesoporous silica nanoparticles for enhanced prostate cancer therapy.
Saroj S; Rajput SJ
Drug Dev Ind Pharm; 2019 Apr; 45(4):532-547. PubMed ID: 30582382
[TBL] [Abstract][Full Text] [Related]
4. Folic acid modified lipid-bilayer coated mesoporous silica nanoparticles co-loading paclitaxel and tanshinone IIA for the treatment of acute promyelocytic leukemia.
Li Z; Zhang Y; Zhu C; Guo T; Xia Q; Hou X; Liu W; Feng N
Int J Pharm; 2020 Aug; 586():119576. PubMed ID: 32603839
[TBL] [Abstract][Full Text] [Related]
5. Tailor-made pH-sensitive polyacrylic acid functionalized mesoporous silica nanoparticles for efficient and controlled delivery of anti-cancer drug Etoposide.
Saroj S; Rajput SJ
Drug Dev Ind Pharm; 2018 Jul; 44(7):1198-1211. PubMed ID: 29412022
[TBL] [Abstract][Full Text] [Related]
6. Physical Characterization and Safety Evaluation of Folic Acid-conjugated Mesoporous Silica Nanoparticles Loaded with Rhodojaponin III.
Yang Q; Zhao C; Yang J; Zhao J; Feng Y; Liu M; Zhang J
Curr Drug Deliv; 2023; 20(10):1559-1568. PubMed ID: 36366851
[TBL] [Abstract][Full Text] [Related]
7. PEG-templated mesoporous silica nanoparticles exclusively target cancer cells.
Morelli C; Maris P; Sisci D; Perrotta E; Brunelli E; Perrotta I; Panno ML; Tagarelli A; Versace C; Casula MF; Testa F; Andò S; Nagy JB; Pasqua L
Nanoscale; 2011 Aug; 3(8):3198-207. PubMed ID: 21725561
[TBL] [Abstract][Full Text] [Related]
8. Effect of pH-responsive alginate/chitosan multilayers coating on delivery efficiency, cellular uptake and biodistribution of mesoporous silica nanoparticles based nanocarriers.
Feng W; Nie W; He C; Zhou X; Chen L; Qiu K; Wang W; Yin Z
ACS Appl Mater Interfaces; 2014 Jun; 6(11):8447-60. PubMed ID: 24745551
[TBL] [Abstract][Full Text] [Related]
9. Targeted and controlled drug delivery by multifunctional mesoporous silica nanoparticles with internal fluorescent conjugates and external polydopamine and graphene oxide layers.
Tran AV; Shim K; Vo Thi TT; Kook JK; An SSA; Lee SW
Acta Biomater; 2018 Jul; 74():397-413. PubMed ID: 29775731
[TBL] [Abstract][Full Text] [Related]
10. Controlled synthesis and size effects of multifunctional mesoporous silica nanosystem for precise cancer therapy.
Ma B; He L; You Y; Mo J; Chen T
Drug Deliv; 2018 Nov; 25(1):293-306. PubMed ID: 29334793
[TBL] [Abstract][Full Text] [Related]
11. Chitosan-capped mesoporous silica nanoparticles as pH-responsive nanocarriers for controlled drug release.
Hu X; Wang Y; Peng B
Chem Asian J; 2014 Jan; 9(1):319-27. PubMed ID: 24115568
[TBL] [Abstract][Full Text] [Related]
12. Folate/N-acetyl glucosamine conjugated mesoporous silica nanoparticles for targeting breast cancer cells: A comparative study.
Kumar P; Tambe P; Paknikar KM; Gajbhiye V
Colloids Surf B Biointerfaces; 2017 Aug; 156():203-212. PubMed ID: 28531877
[TBL] [Abstract][Full Text] [Related]
13. TPGS functionalized mesoporous silica nanoparticles for anticancer drug delivery to overcome multidrug resistance.
Zhao P; Li L; Zhou S; Qiu L; Qian Z; Liu X; Cao X; Zhang H
Mater Sci Eng C Mater Biol Appl; 2018 Mar; 84():108-117. PubMed ID: 29519418
[TBL] [Abstract][Full Text] [Related]
14. Targeted delivery of quercetin loaded mesoporous silica nanoparticles to the breast cancer cells.
Sarkar A; Ghosh S; Chowdhury S; Pandey B; Sil PC
Biochim Biophys Acta; 2016 Oct; 1860(10):2065-75. PubMed ID: 27392941
[TBL] [Abstract][Full Text] [Related]
15. Ultrasound-Triggered Destruction of Folate-Functionalized Mesoporous Silica Nanoparticle-Loaded Microbubble for Targeted Tumor Therapy.
Lv Y; Cao Y; Li P; Liu J; Chen H; Hu W; Zhang L
Adv Healthc Mater; 2017 Sep; 6(18):. PubMed ID: 28671341
[TBL] [Abstract][Full Text] [Related]
16. Cancer-targeted and intracellular delivery of Bcl-2-converting peptide with functional macroporous silica nanoparticles for biosafe treatment.
Wu Y; Ge P; Xu W; Li M; Kang Q; Zhang X; Xie J
Mater Sci Eng C Mater Biol Appl; 2020 Mar; 108():110386. PubMed ID: 31923940
[TBL] [Abstract][Full Text] [Related]
17. Tailoring Particle Size of Mesoporous Silica Nanosystem To Antagonize Glioblastoma and Overcome Blood-Brain Barrier.
Mo J; He L; Ma B; Chen T
ACS Appl Mater Interfaces; 2016 Mar; 8(11):6811-25. PubMed ID: 26911360
[TBL] [Abstract][Full Text] [Related]
18. Ingenious pH-sensitive etoposide loaded folic acid decorated mesoporous silica-carbon dot with carboxymethyl-βcyclodextrin gatekeeper for targeted drug delivery and imaging.
Shirani MP; Rezaei B; Khayamian T; Dinari M; Shamili FH; Ramezani M; Alibolandi M
Mater Sci Eng C Mater Biol Appl; 2018 Nov; 92():892-901. PubMed ID: 30184819
[TBL] [Abstract][Full Text] [Related]
19. Folic Acid-Polyethyleneimine Functionalized Mesoporous Silica Nanoparticles as a Controlled Release Nanocarrier.
Park J; Park SS; Jo NJ; Ha CS
J Nanosci Nanotechnol; 2019 Oct; 19(10):6217-6224. PubMed ID: 31026940
[TBL] [Abstract][Full Text] [Related]
20. Mesoporous silica nanoparticles combining Au particles as glutathione and pH dual-sensitive nanocarriers for doxorubicin.
Xu S; Li Y; Chen Z; Hou C; Chen T; Xu Z; Zhang X; Zhang H
Mater Sci Eng C Mater Biol Appl; 2016 Feb; 59():258-264. PubMed ID: 26652372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
